Hartford Financial Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18	Closed	-$667	–	387
2024 Q2	$667	Hold	18	–	–	﹤0.01%	378
2024 Q1	$756	Hold	18	–	–	﹤0.01%	376
2023 Q4	$714	Hold	18	–	–	﹤0.01%	385
2023 Q3	$496	Hold	18	–	–	﹤0.01%	386
2023 Q2	$611	Hold	18	–	–	﹤0.01%	365
2023 Q1	$648	Hold	18	–	–	﹤0.01%	373
2022 Q4	$802	Hold	18	–	–	﹤0.01%	366
2022 Q3	$1K	Buy	+18	New	+$1K	﹤0.01%	367
2022 Q2	–	Sell	-18	Closed	-$1K	–	386
2022 Q1	$1K	Hold	18	–	–	﹤0.01%	379
2021 Q4	$1K	Hold	18	–	–	﹤0.01%	355
2021 Q3	$1K	Hold	18	–	–	﹤0.01%	386
2021 Q2	$1K	Buy	+18	New	+$1K	﹤0.01%	370
2017 Q3	–	Sell	-18	Closed	–	–	389
2017 Q2	$0	Buy	+18	New	–	﹤0.01%	369
2017 Q1	–	Sell	-18	Closed	-$1K	–	347
2016 Q4	$1K	Hold	18	–	–	﹤0.01%	310
2016 Q3	$1K	Hold	18	–	–	﹤0.01%	311
2016 Q2	$1K	Hold	18	–	–	﹤0.01%	294
2016 Q1	$1K	Hold	18	–	–	﹤0.01%	294
2015 Q4	$4K	Hold	18	–	–	﹤0.01%	248
2015 Q3	$2K	Hold	18	–	–	﹤0.01%	242
2015 Q2	$6K	Buy	+18	New	+$6K	﹤0.01%	231
2015 Q1	–	Sell	-18	Closed	-$4K	–	131
2014 Q4	$4K	Hold	18	–	–	﹤0.01%	231
2014 Q3	$3K	Hold	18	–	–	﹤0.01%	265
2014 Q2	$4K	Hold	18	–	–	﹤0.01%	258
2014 Q1	$4K	Hold	18	–	–	﹤0.01%	237
2013 Q4	$6K	Hold	18	–	–	﹤0.01%	215
2013 Q3	$9K	Hold	18	–	–	0.01%	210
2013 Q2	$4K	Buy	+18	New	+$4K	﹤0.01%	241